The traditional Chinese medicine (TCM) chain "He Sheng Ding Ji Tang" recently secured tens of millions in angel round funding, planning to establish a TCM hospital in Beijing. Founded in 2013 and part of He Sheng Oriental Group, the company specializes in TCM treatments, education, and dietary products, with a focus on research and innovation, offering a wide range of trusted products.
EqualOcean has learned that the traditional Chinese medicine (TCM) chain institution "Hesheng Dingjitang" recently received multi-million yuan angel round financing, led by Northern Light Venture Capital. This funding will primarily be used to establish a TCM hospital in a prime location in Beijing. The hospital, which is currently in the renovation phase, is expected to cover an area of 3,000 square meters and accommodate 2,000 patient visits per day.
Hesheng Dingjitang is a subsidiary of Weshare Group and operates three main business segments: TCM chain clinics, TCM education and training, and TCM dietary products. Established in 2013, Hesheng Dingjitang was one of the earliest medical institutions in Beijing to focus on pediatric tuina (a form of Chinese therapeutic massage). Currently, Hesheng Oriental Group has established two clinics, one outpatient department, and one internet hospital. Additionally, one primary TCM hospital and a youth wellness center are under construction.
Hesheng Dingjitang offers a wide range of products, including Chinese herbal pieces, ready-made traditional medicines, TCM health products, and TCM beauty products. The company produces a variety of Chinese herbal pieces, adhering strictly to the standards of the national pharmacopeia, ensuring reliable quality trusted by TCM practitioners and patients alike. The ready-made traditional medicines include numerous classic TCM formulas and proprietary recipes suitable for treating various common and chronic diseases. The TCM health and beauty products are new categories developed by the company in response to modern health concepts and market demands, receiving widespread acclaim from consumers.
Emphasizing research investment and technological innovation, Hesheng Dingjitang has established a dedicated research center staffed by TCM experts, biomedical scholars, and technical engineers. In recent years, the company has achieved multiple research outcomes in new TCM drug development, modernization of classic prescriptions, and improvements in TCM preparation processes, obtaining several national patents. These research achievements have not only enhanced product quality and efficacy but also provided robust technical support for the company's sustainable development.
The medical team at Hesheng Dingjitang mainly comprises graduates from Beijing University of Chinese Medicine and the China Academy of Chinese Medical Sciences. Over the past ten years, the clinics have served more than 100,000 patients, with the current offline daily patient volume stable at around 200. Hesheng Dingjitang specializes in external TCM treatments, using physical methods such as acupuncture, tuina, herbal baths, and cupping to stimulate meridians and acupoints and correct musculoskeletal imbalances. The institution also integrates internal treatments, having developed a comprehensive general practice system, particularly accumulating extensive experience in treating common diseases in women and children.